US 9273124
Monoclonal antibodies that react with the capsule of Bacillus anthracis
granted A61KA61K2039/505A61K39/07
Quick answer
US patent 9273124 (Monoclonal antibodies that react with the capsule of Bacillus anthracis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/07, A61K39/3955, A61K39/40